This association between higher TIL levels and pCR has been confirmed in ICORG 10-05, with <5% residual tumour and reduced tumour-associated CD4+ and CD8+ T cells after one cycle of therapy in the pCR cohort [40]. This evidence concerns the gene CD8A and neoplasm.